Adalyn Hetzel had just celebrated her second birthday in the spring of 2024 when doctors at Children’s Hospital of ...
Despite such guidelines, though, the investigators said there is a lack of evidence-based or widely accepted consensus on ...
Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...
New research from Dartmouth Health and Dartmouth Cancer Center reveals a glowing molecule designed to highlight soft-tissue sarcomas during surgery, paving the way for more precise tumor removal and ...
The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results